Longitudinal antimüllerian hormone and its correlation with pubertal milestones

Reproductive Endocrinology

Like Comment
Related Content

VOLUME 2, ISSUE 2, P238-244, JUNE 01, 2021


Meghan B. Smith, M.D., Jacqueline Ho, MD, M.S., Lihong Ma, M.D., Miryoung Lee, Ph.D., Stefan A. Czerwinski, Ph.D., Tanya L. Glenn, M.D., David R. Cool, Ph.D., Pascal Gagneux, Ph.D., Frank Z. Stanczyk, Ph.D., Lynda K. McGinnis, Ph.D., Steven R. Lindheim, M.D., M.M.M. 



To examine the changes in AMH levels longitudinally over time and their relationship with both body composition, particularly abdominal adiposity, and milestones of pubertal development in female children.


Secondary analysis of a prospective, longitudinal study.


University affiliated research center and laboratories.


Eighty-nine females were examined between 1990 and 2015 to study child growth and development.


Demographic, anthropometric, growth, and pubertal milestone data with serum samples stored and subsequently analyzed for AMH.

Main Outcome Measure(s)

Longitudinal change in AMH and predicted AMH levels based on body composition, age, and pubertal milestones including, pubarche, thelarche, and menarche.


Natural log-transformed AMH (AMHlog) levels appeared to have a nonlinear relationship with age, decreasing between 10 and 14 years of age, increasing until 16 years. A mixed effect linear model demonstrated that increased abdominal adiposity (waist/height ratio, WHtR) was significantly associated with the predicted increased AMHlog levels (β=1.37). As females progressed through the Tanner stages, the model predicted decreasing AMHlog values when adjusting for age and WHtR.


Declining AMH levels during puberty may not be reflective of diminished ovarian reserve as observed in adults, but may suggest a permissive role of AMH in the activation of the hypothalamic-pituitary-ovarian axis.

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders.